RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
VAFRX
Price
$27.50
Change
-$0.37 (-1.33%)
Updated
Jun 13 closing price
Net Assets
16.35B
Interact to see
Advertisement

RGEBX vs VAFRX

Header iconRGEBX vs VAFRX Comparison
Open Charts RGEBX vs VAFRXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
Invesco American Franchise R
Price$27.50
Change-$0.37 (-1.33%)
VolumeN/A
Net Assets16.35B
RGEBX vs VAFRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGEBX vs. VAFRX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and VAFRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. VAFRX (16.4B). RGEBX (0.00) and VAFRX (0.00) have matching dividends . RGEBX was incepted earlier than VAFRX: RGEBX (11 years) vs VAFRX (14 years). VAFRX (1.21) is less costly to investors than RGEBX (1.09). VAFRX is a more actively managed with annual turnover of: 51.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than VAFRX: RGEBX (250) vs VAFRX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. VAFRX (7.13). RGEBX return over 5 years is better than : 45.42 vs. VAFRX (20.09).
RGEBXVAFRXRGEBX / VAFRX
Total Expense Ratio1.091.2190%
Annual Report Gross Expense Ratio1.091.2190%
Fund Existence11 years14 years-
Gain YTD4.829-0.578-835%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets306B16.4B1,866%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.687.13108%
Returns for 3 years51.0160.5484%
Returns for 5 years45.4220.09226%
Returns for 10 years65.8760.72108%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd